Memorial Sloan Kettering Cancer Center: Glioblastoma trials

The registry lists 14 Glioblastoma studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 3 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 4Phase 2 7No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of 177Lu-PSMA-617 in People With GliomasRecruitingNCT07223034Phase 1
• Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaRecruitingNCT06934889Phase 1
• Trastuzumab Deruxtecan (T-DXd) for People With Brain CancerRecruitingNCT06058988Phase 2
• 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma MultiformeCompletedNCT02410577Not applicableResults posted
• Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant GliomaCompletedNCT00498927Phase 2Results posted
• Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/GlioblastomaCompletedNCT00200161Phase 2Results posted
• Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate CancerCompletedNCT00085566Phase 1/2Results posted
• Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor GlioblastomaWithdrawnNCT05927610Not applicable
• Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating FieldsActive, not recruitingNCT04469075Phase 2
• Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated GlioblastomaActive, not recruitingNCT03743662Phase 2
• Easing Psychosocial Burden for Informal CaregiversCompletedNCT03454295Early Phase 1
• Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and CaregiversActive, not recruitingNCT02375841
• Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant GliomaCompletedNCT01392209Phase 1
• Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00022256Phase 2